JP2014501716A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014501716A5 JP2014501716A5 JP2013538794A JP2013538794A JP2014501716A5 JP 2014501716 A5 JP2014501716 A5 JP 2014501716A5 JP 2013538794 A JP2013538794 A JP 2013538794A JP 2013538794 A JP2013538794 A JP 2013538794A JP 2014501716 A5 JP2014501716 A5 JP 2014501716A5
- Authority
- JP
- Japan
- Prior art keywords
- hydroxyamino
- methyl
- benzamide
- hydroxymethyl
- diynyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41231110P | 2010-11-10 | 2010-11-10 | |
| US61/412,311 | 2010-11-10 | ||
| PCT/US2011/059280 WO2012154204A1 (en) | 2010-11-10 | 2011-11-04 | Hydroxamic acid derivatives and their use in the treatment of bacterial infections |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014501716A JP2014501716A (ja) | 2014-01-23 |
| JP2014501716A5 true JP2014501716A5 (enExample) | 2014-12-18 |
Family
ID=46317476
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013538794A Pending JP2014501716A (ja) | 2010-11-10 | 2011-11-04 | ヒドロキサム酸誘導体および細菌感染の処置におけるその使用 |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP2638006A1 (enExample) |
| JP (1) | JP2014501716A (enExample) |
| KR (1) | KR20140023869A (enExample) |
| CN (1) | CN103298780A (enExample) |
| AR (1) | AR083760A1 (enExample) |
| AU (1) | AU2011367819A1 (enExample) |
| BR (1) | BR112013011693A2 (enExample) |
| CA (1) | CA2817211A1 (enExample) |
| EA (1) | EA201390626A1 (enExample) |
| IL (1) | IL226270A0 (enExample) |
| MX (1) | MX2013005200A (enExample) |
| SG (1) | SG190243A1 (enExample) |
| TW (1) | TW201249786A (enExample) |
| WO (1) | WO2012154204A1 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008154642A2 (en) | 2007-06-12 | 2008-12-18 | Achaogen, Inc. | Antibacterial agents |
| WO2013170030A1 (en) * | 2012-05-09 | 2013-11-14 | Achaogen, Inc. | Antibacterial agents |
| WO2013170165A1 (en) | 2012-05-10 | 2013-11-14 | Achaogen, Inc. | Antibacterial agents |
| AR097617A1 (es) | 2013-09-13 | 2016-04-06 | Actelion Pharmaceuticals Ltd | Derivados antibacterianos del 2h-indazol |
| TR201807881T4 (tr) | 2013-12-19 | 2018-06-21 | Idorsia Pharmaceuticals Ltd | Antibakteriyel 1h-ındazol ve 1h-ındol türevleri. |
| AR099612A1 (es) | 2014-03-04 | 2016-08-03 | Actelion Pharmaceuticals Ltd | Derivados antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona |
| US9539305B1 (en) | 2014-03-14 | 2017-01-10 | Fleurir Abx Llc | Pristinamycin compositions, LpxC compositions, their improvements, and combinations thereof |
| JP2017515906A (ja) | 2014-05-16 | 2017-06-15 | アクテリオン ファーマシューティカルズ リミテッドＡｃｔｅｌｉｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｌｔｄ | 抗菌性キナゾロン−４（３ｈ）−オン誘導体 |
| KR20170086079A (ko) | 2014-11-19 | 2017-07-25 | 액테리온 파마슈티칼 리미티드 | 항균성 벤조티아졸 유도체 |
| EA032138B1 (ru) | 2014-12-16 | 2019-04-30 | Новартис Аг | СОЕДИНЕНИЯ ИЗОКСАЗОЛГИДРОКСАМИНОВОЙ КИСЛОТЫ В КАЧЕСТВЕ ИНГИБИТОРОВ LpxC |
| EP3448375B1 (en) | 2016-04-25 | 2023-09-27 | Duke University | Benzoylglycine derivatives and methods of making and using same |
| CA3026356A1 (en) | 2016-06-14 | 2017-12-21 | Novartis Ag | Crystalline form of (r)-4-(5-(cyclopropylethynyl)isoxazol-3-yl)-n-hydroxy-2-methyl-2-(methylsulfonyl)butanamide as an antibacterial agent |
| WO2017223349A1 (en) | 2016-06-23 | 2017-12-28 | Achaogen, Inc. | Antibacterial agents |
| CA3090833A1 (en) * | 2018-02-10 | 2019-08-15 | Kbp Biosciences Co., Ltd. | Compound acting as antibiotics |
| CN110563611B (zh) * | 2019-09-19 | 2021-02-02 | 中国医学科学院医药生物技术研究所 | 一种异羟肟酸类衍生物及其制备方法和应用 |
| CN113957098A (zh) * | 2021-09-13 | 2022-01-21 | 湖南工业大学 | 普罗威登斯属细菌菌株在制备二价锰氧化剂中的应用 |
| CN116730870B (zh) * | 2023-08-08 | 2023-10-13 | 中国医学科学院医药生物技术研究所 | 异羟肟酸类化合物或其可药用盐、及其用途和制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5925659A (en) | 1996-05-07 | 1999-07-20 | Merck & Co., Inc. | Antibacterial agents |
| US6541276B2 (en) | 1996-10-28 | 2003-04-01 | Versicor, Inc. | Methods for solid-phase synthesis of hydroxylamine compounds and derivatives and combinatorial libraries thereof |
| WO2000061134A1 (en) | 1999-04-09 | 2000-10-19 | British Biotech Pharmaceuticals Limited | Antimicrobial agents |
| SG2012000667A (en) * | 2003-01-08 | 2015-03-30 | Univ Washington | Antibacterial agents |
| DE102006032709A1 (de) | 2006-07-14 | 2008-01-17 | BSH Bosch und Siemens Hausgeräte GmbH | Luftschallgedämmte Lebensmittelmühle |
| CN101209974A (zh) * | 2006-12-31 | 2008-07-02 | 天津药物研究院 | 异羟肟酸类衍生物及其用途 |
| WO2008154642A2 (en) * | 2007-06-12 | 2008-12-18 | Achaogen, Inc. | Antibacterial agents |
| WO2011005355A1 (en) * | 2009-05-07 | 2011-01-13 | Achaogen, Inc. | Combinations comprising a lpxc inhibitor and an antibiotic for use in the treatment of infections caused by gram-negative bacteria |
| PH12012502087A1 (en) * | 2010-04-20 | 2015-04-15 | Taisho Pharmaceutical Co Ltd | Novel hydroxamic acid derivative |
-
2011
- 2011-11-04 MX MX2013005200A patent/MX2013005200A/es not_active Application Discontinuation
- 2011-11-04 AR ARP110104117A patent/AR083760A1/es not_active Application Discontinuation
- 2011-11-04 WO PCT/US2011/059280 patent/WO2012154204A1/en not_active Ceased
- 2011-11-04 AU AU2011367819A patent/AU2011367819A1/en not_active Abandoned
- 2011-11-04 CN CN2011800639128A patent/CN103298780A/zh active Pending
- 2011-11-04 BR BR112013011693A patent/BR112013011693A2/pt not_active IP Right Cessation
- 2011-11-04 EA EA201390626A patent/EA201390626A1/ru unknown
- 2011-11-04 SG SG2013036272A patent/SG190243A1/en unknown
- 2011-11-04 TW TW100140449A patent/TW201249786A/zh unknown
- 2011-11-04 EP EP11849908.6A patent/EP2638006A1/en not_active Withdrawn
- 2011-11-04 KR KR1020137012799A patent/KR20140023869A/ko not_active Withdrawn
- 2011-11-04 CA CA2817211A patent/CA2817211A1/en not_active Abandoned
- 2011-11-04 JP JP2013538794A patent/JP2014501716A/ja active Pending
-
2013
- 2013-05-09 IL IL226270A patent/IL226270A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014501716A5 (enExample) | ||
| JP2012502946A5 (enExample) | ||
| US11352315B2 (en) | Compositions and methods comprising a triaryl polyamine | |
| JP2003506354A5 (enExample) | ||
| RU2014134720A (ru) | Противомикробные композиции, содержащие dgla, 15-онера и/или 15-hetre, и способы их применения | |
| EA201400358A1 (ru) | Замещенные n-[1-циано-2-(фенил)этил]-2-азабицикло[2.2.1]гептан-3-карбоксамидные ингибиторы катепсина с | |
| JP2015502974A5 (enExample) | ||
| EP2662353A3 (en) | Antibacterial agents | |
| JP2009523760A5 (enExample) | ||
| JP2012522037A5 (enExample) | ||
| JP2011529964A5 (enExample) | ||
| EA200970535A1 (ru) | Антибактериальные производные хинолина | |
| JP2013508299A5 (enExample) | ||
| WO2010115184A3 (en) | Hydroxythienoquinolones and related compounds as anti-infective agents | |
| CA2471943A1 (en) | .beta.-amyloid protein production-secretion inhibitors | |
| US20140073558A1 (en) | Novel antibacterial agents for the treatment of gram positive infections | |
| US10464896B2 (en) | Efflux-pump inhibitors and therapeutic uses thereof | |
| JP2018500387A5 (enExample) | ||
| AU2012296543A1 (en) | Methods of treating bacterial infections with 1,2-benzisothiazolinone and isoindolinone derivatives | |
| SE1551572A1 (sv) | Compounds and methods of treating bacterial infections | |
| EA200970534A1 (ru) | Антибактериальные производные хинолина | |
| PH12020551772A1 (en) | Oxo-substituted compound | |
| WO2020117755A1 (en) | Compositions and methods for treating biofilms | |
| WO2008028805A3 (de) | Verwendung einer pharmazeutischen zusammensetzung enthaltend ein anticholinergikum zur abtötung von mikroorganismen und zur behandlung von atemwegsinfektionen | |
| WO2008094912B1 (en) | Substituted gamma lactams as therapeutic agents |